Circular RNA circGSE1 promotes angiogenesis in ageing mice by targeting the miR-323-5p/NRP1 axis

Jiacong Qiu1,2,3, Rencong Chen1,2,3, Lei Zhao1,2,3

  • 1Division of Vascular Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, Guangdong, China.

Aging
|April 2, 2022
PubMed

Insights

Circular RNA circGSE1 promotes blood vessel formation in aging endothelial cells by regulating the miR-323-5p/NRP1 pathway, offering a potential therapeutic target for age-related cardiovascular issues.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Aging Research

Background:

  • Endothelial cells (ECs) are crucial in cardiovascular health, with aging impairing their function and contributing to disease.
  • Circular RNAs (circRNAs) are implicated in cardiovascular diseases, but their role in age-related endothelial dysfunction and angiogenesis remains largely unknown.

Purpose of the Study:

  • To identify a functional circRNA regulating angiogenesis in aging ECs.
  • To elucidate the underlying molecular mechanism of this circRNA in promoting endothelial angiogenesis during aging.

Main Methods:

  • CircRNA sequencing to identify differentially expressed circRNAs in old (OECs) versus young (YECs) endothelial cells.
  • In vitro assays (proliferation, migration, tube formation) to assess circGSE1 function in OECs.
  • In vivo mouse model (femoral artery ligation) to evaluate circGSE1's effect on angiogenesis in aging mice.

Main Results:

  • circGSE1 was significantly downregulated in OECs compared to YECs.
  • Overexpression of circGSE1 enhanced proliferation, migration, and tube formation in OECs in vitro.
  • circGSE1 promoted blood flow recovery and angiogenesis in ischemic limbs of aging mice, acting via the miR-323-5p/NRP1 axis.

Conclusions:

  • circGSE1 plays a vital role in promoting endothelial angiogenesis during aging.
  • The circGSE1/miR-323-5p/NRP1 axis is a key mechanism regulating angiogenesis in aging ECs.
  • This axis represents a promising therapeutic target for enhancing angiogenesis in aging-related cardiovascular conditions.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.0K